CS381891A3 - Benzodiazepinones - Google Patents
Benzodiazepinones Download PDFInfo
- Publication number
- CS381891A3 CS381891A3 CS913818A CS381891A CS381891A3 CS 381891 A3 CS381891 A3 CS 381891A3 CS 913818 A CS913818 A CS 913818A CS 381891 A CS381891 A CS 381891A CS 381891 A3 CS381891 A3 CS 381891A3
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- hiv
- infections
- hydrogen
- chloro
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62855190A | 1990-12-17 | 1990-12-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS381891A3 true CS381891A3 (en) | 1992-07-15 |
Family
ID=24519378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS913818A CS381891A3 (en) | 1990-12-17 | 1991-12-16 | Benzodiazepinones |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0491218A1 (is) |
| JP (1) | JPH04275287A (is) |
| KR (1) | KR920012070A (is) |
| CN (1) | CN1062528A (is) |
| AU (1) | AU8974191A (is) |
| BR (1) | BR9105406A (is) |
| CA (1) | CA2057646A1 (is) |
| CS (1) | CS381891A3 (is) |
| FI (1) | FI915915A7 (is) |
| HU (1) | HUT59920A (is) |
| IE (1) | IE914369A1 (is) |
| IL (1) | IL100364A0 (is) |
| IS (1) | IS3792A7 (is) |
| MX (1) | MX9102580A (is) |
| NO (1) | NO914968L (is) |
| PT (1) | PT99821A (is) |
| YU (1) | YU194691A (is) |
| ZA (1) | ZA919850B (is) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW221687B (is) * | 1992-01-24 | 1994-03-11 | Hoffmann La Roche | |
| CA2106387A1 (en) * | 1992-02-26 | 1993-08-27 | F. Hoffmann-La Roche Ag | Benzodiazepinones |
| US5888992A (en) * | 1992-03-11 | 1999-03-30 | Narhex Limited | Polar substituted hydrocarbons |
| MXPA93002392A (es) | 1992-03-11 | 2005-02-04 | Narhex Ltd | Derivados amino de hidrocarburos-oxo e hidroxi-substituidos. |
| US6071895A (en) * | 1992-03-11 | 2000-06-06 | Narhex Limited | Polar-substituted hydrocarbons |
| JPH07504654A (ja) * | 1992-03-11 | 1995-05-25 | ナルヘックス リミテッド | オキソ及びヒドロキシ置換炭化水素のアミン誘導体 |
| SI9300288A (sl) * | 1992-06-16 | 1993-12-31 | Hoffmann La Roche | Benzodiazepini |
| US5665720A (en) * | 1992-08-07 | 1997-09-09 | Merck & Co., Inc. | Benzoxazinones as inhibitors of HIV reverse transcriptase |
| US5939430A (en) * | 1993-02-22 | 1999-08-17 | Merrell Pharmaceuticals Inc. | Combinations of retroviral inhibitors |
| JP3647451B2 (ja) * | 1993-09-30 | 2005-05-11 | 塩野義製薬株式会社 | ベンゾラクタム誘導体 |
| IT1297090B1 (it) * | 1997-12-01 | 1999-08-03 | Barbara Ensoli | Tat di hiv-1 o suoi derivati, da soli od in combinazione, a scopo vaccinale, profilattico e terapeutico, contro l'aids i tumori e le |
| DE19920955C2 (de) * | 1999-05-06 | 2002-11-28 | Wacker Chemie Gmbh | 2-(Benz-)Imidazol-,2-(Benz-)Oxazol- und 2-(Benz-)Thiazol-substituierte Silane und Verfahren zu deren Herstellung |
| NZ538870A (en) | 2002-09-20 | 2007-04-27 | Arrow Therapeutics Ltd | Benzodiazepine derivatives and pharmaceutical compositions containing them |
| CA2529227A1 (en) * | 2003-06-26 | 2005-01-06 | Merck & Co., Inc. | Benzodiazepine cgrp receptor antagonists |
| GB0406279D0 (en) * | 2004-03-19 | 2004-04-21 | Arrow Therapeutics Ltd | Therapeutic compounds |
| GB0406282D0 (en) * | 2004-03-19 | 2004-04-21 | Arrow Therapeutics Ltd | Therapeutic compounds |
| GB0406280D0 (en) * | 2004-03-19 | 2004-04-21 | Arrow Therapeutics Ltd | Chemical compounds |
| BRPI0520554A2 (pt) | 2005-09-19 | 2009-06-13 | Arrow Therapeutics Ltd | uso de uma benzodiazepina ou um sal farmaceuticamente aceitável do mesmo, método para tratar ou prevenir uma infecção por hcv em um paciente, derivado de benzodiazepina ou um sal famaceuticamente aceitável do mesmo, e, composição farmacêutica |
| WO2007110337A1 (en) | 2006-03-29 | 2007-10-04 | F. Hoffmann-La Roche Ag | Pyridine and pyrimidine derivatives as mglur2 antagonists |
| CU20090172A7 (es) | 2009-10-09 | 2011-10-05 | Ct De Investigación Y Desarrollo De Medicamentos | Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular |
| NZ722345A (en) * | 2014-02-14 | 2018-02-23 | Inception 2 Inc | Pyrazolone compounds and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL122319C (is) * | 1961-06-20 | |||
| IE903879A1 (en) * | 1989-10-30 | 1991-05-08 | Hoffmann La Roche | Use of a benzodiazepine and a phenylpyrrylketone derivative |
-
1991
- 1991-12-03 EP EP91120709A patent/EP0491218A1/en not_active Withdrawn
- 1991-12-13 BR BR919105406A patent/BR9105406A/pt unknown
- 1991-12-13 IL IL100364A patent/IL100364A0/xx unknown
- 1991-12-13 ZA ZA919850A patent/ZA919850B/xx unknown
- 1991-12-13 CA CA002057646A patent/CA2057646A1/en not_active Abandoned
- 1991-12-16 NO NO91914968A patent/NO914968L/no unknown
- 1991-12-16 FI FI915915A patent/FI915915A7/fi not_active Application Discontinuation
- 1991-12-16 CS CS913818A patent/CS381891A3/cs unknown
- 1991-12-16 AU AU89741/91A patent/AU8974191A/en not_active Abandoned
- 1991-12-16 CN CN91108018A patent/CN1062528A/zh active Pending
- 1991-12-16 JP JP3351723A patent/JPH04275287A/ja active Pending
- 1991-12-16 IE IE436991A patent/IE914369A1/en not_active Application Discontinuation
- 1991-12-16 HU HU913960A patent/HUT59920A/hu unknown
- 1991-12-16 MX MX9102580A patent/MX9102580A/es unknown
- 1991-12-16 PT PT99821A patent/PT99821A/pt not_active Application Discontinuation
- 1991-12-16 KR KR1019910023068A patent/KR920012070A/ko not_active Withdrawn
- 1991-12-16 IS IS3792A patent/IS3792A7/is unknown
- 1991-12-17 YU YU194691A patent/YU194691A/sh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI915915L (fi) | 1992-06-18 |
| IL100364A0 (en) | 1992-09-06 |
| ZA919850B (en) | 1992-08-26 |
| NO914968L (no) | 1992-06-18 |
| JPH04275287A (ja) | 1992-09-30 |
| IS3792A7 (is) | 1992-06-18 |
| IE914369A1 (en) | 1992-06-17 |
| EP0491218A1 (en) | 1992-06-24 |
| MX9102580A (es) | 1992-06-01 |
| KR920012070A (ko) | 1992-07-25 |
| CA2057646A1 (en) | 1992-06-18 |
| PT99821A (pt) | 1992-12-31 |
| FI915915A7 (fi) | 1992-06-18 |
| YU194691A (sh) | 1994-01-20 |
| HU913960D0 (en) | 1992-02-28 |
| BR9105406A (pt) | 1992-08-25 |
| HUT59920A (en) | 1992-07-28 |
| FI915915A0 (fi) | 1991-12-16 |
| NO914968D0 (no) | 1991-12-16 |
| CN1062528A (zh) | 1992-07-08 |
| AU8974191A (en) | 1992-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CS381891A3 (en) | Benzodiazepinones | |
| JP2001505873A (ja) | Ｈｉｖ逆転写酵素阻害剤として有用な４，４―二置換―１，４―ジヒドロ―２ｈ―３，１―ベンゾオキサジン―２―オン類、およびそれらを製造するための中間体および方法 | |
| KR100717489B1 (ko) | 피리도피리미디논 화합물, 이의 제조 방법 및 이를함유하는 약제 조성물 | |
| CA3197470A1 (en) | Bicyclic compounds | |
| MXPA04006030A (es) | Antiviricos de piridoquinoxalina. | |
| JP4231107B2 (ja) | 抗ウイルス作用を有する置換キノリン誘導体 | |
| US5087625A (en) | Pyridodiazepines and their use in the prevention or treatment of HIV infection | |
| JPH0225486A (ja) | 新規イミダゾキノキサリン化合物、その製造方法並びにその使用 | |
| JP2011529085A (ja) | 抗ウイルス化合物 | |
| EP0475231A1 (en) | Benzodiazepines | |
| US5034531A (en) | Fused polycyclic pyranyl compounds as antiviral agents | |
| SI9500260A (en) | Substituted quinolin derivatives, process for their preparation and use thereof | |
| US4497814A (en) | 2-(Pyridinyl)-1,2,4-triazolo[1,5-a]pyrimidines and derivatives useful in increasing cardiac contractility | |
| SK61593A3 (en) | Benzodiazepine derivatives having antiviral activity | |
| HU183733B (en) | Process for preparing triazolo-benzodiazepine derivatives | |
| WO2000078750A1 (en) | New pharmaceutically active compounds | |
| US6140320A (en) | 5,5-disubstituted-1,5-dihydro-4,1-benzoxazepin-2 (3H)-ones useful as HIV reverse transcriptase inhibitors | |
| AU3497293A (en) | Benzodiazepinones and medicines containing them | |
| US4547501A (en) | Method of using [1,2,4]triazolo[4,3-a]quinoxaline-4-amine derivatives as antidepressant and antifatigue agents | |
| JPS59141580A (ja) | インド−ル誘導体 | |
| CZ372792A3 (en) | Pyrrolylbenzodiazepinones, processes of their preparation and medicaments based thereon | |
| CA3136519A1 (en) | Fused heterocycle derivatives as capsid assembly modulators | |
| HK40081945A (en) | Bicyclic agonists of stimulator of interferon genes sting | |
| JPH085884B2 (ja) | ５Ｈ−ピラゾロ〔４，３−ａ〕キノリジン−５−オン誘導体 | |
| JPH05262774A (ja) | ピロロ［３，２−ｅピラゾロ［１，５−ａピリミジン誘導体及びこれを含有する循環器系疾患治療剤 |